Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131
Crossref DOI link: https://doi.org/10.1007/s11060-015-1845-7
Published Online: 2015-06-19
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vogelbaum, Michael A.
Hu, Chen
Peereboom, David M.
Macdonald, David R.
Giannini, Caterina
Suh, John H.
Jenkins, Robert B.
Laack, Nadia N.
Brachman, David G.
Shrieve, Dennis C.
Souhami, Luis
Mehta, Minesh P.
Text and Data Mining valid from 2015-06-19